Resources Contact Us Home
Humanized anti-CD70 binding agents and uses thereof

Image Number 17 for United States Patent #8067546.

Disclosed are CD70 binding agents, such as humanized anti-CD70 antibodies and fragments and derivatives, that exert a cytotoxic, cytostatic or immunomodulatory on CD70 expressing cells, as well as pharmaceutical compositions and kits comprising the antibody, fragment or derivative. Also disclosed are methods for the treatment of CD70-expressing cancers and immunological disorders, comprising administering to a subject the CD70 binding agents or pharmaceutical compositions.

  Recently Added Patents
Verbena plant named `Duempsopicha`
Illuminating device
Methods, apparatus, and systems for facilitating control communications between disparate devices
Flash multi-level threshold distribution scheme
Methods and compositions for inhibition of neutrophil exocytosis
Data processor with virtual machine management
Semiconductor device, integrated circuit and method of manufacturing an integrated circuit
  Randomly Featured Patents
Substituted amine derivatives and methods of use
Method and a device for promoting the separation of components suspended in a liquid
Electrode for hydrogen generation, method for manufacturing the same and electrolysis method using the same
System and method for creating electric isolation between layers comprising solar cells
Tape carrier package for liquid crystal display
Concrete pump and method of using same
Housing for a riflescope eyepiece and reticle
Calibration strip and the laser calibration system using thereof
Electrical circuits for timing signals
Recloseable lid with closure plug